In the sprawling world of fungi, there are an estimated 6.3 million species, yet fewer than 150,000 have been described. These organisms play vital roles in our ecosystems, from decomposing organic matter to forming beneficial partnerships with plants. Beyond their ecological significance, fungi have revolutionized medicine and sustainable engineering, with antibiotics like penicillin being a prime example.
Despite their importance, preserving the diverse and often elusive fungal species for long-term study poses significant challenges. Field collection and cultivation are not always feasible, especially for rare or seasonal species. This is where this recent research from Paul Stamets' team at Fungi Perfecti LLC on cryopreservation, the storage of biological samples at extremely low temperatures, offers a promising solution.
![](https://static.wixstatic.com/media/1b52ec_56389486980244cab76072cee2e8a975~mv2.png/v1/fill/w_974,h_1306,al_c,q_90,enc_auto/1b52ec_56389486980244cab76072cee2e8a975~mv2.png)
Why Cryopreservation Matters
Cryopreservation at temperatures below -165°C is the gold standard for maintaining fungal cultures over long periods. This method ensures that fungal strains remain viable, stable, and free from genetic drift, which can occur with traditional cultivation methods. The creation of cryogenic storage systems not only supports biodiversity conservation but also aids in scientific research and commercial applications.
Implementing a Cryogenic Fungal Biobank
Setting up a cryogenic fungal biobank might sound daunting, but recent research provides a practical roadmap. The process involves familiar mycological techniques and affordable materials, making it accessible even to smaller labs. Here’s how it can be done:
Initial Setup: The primary equipment includes a cryogenic storage tank, a -80°C freezer, and controlled-rate freezing containers like Mr. Frosty and CoolCell. These items, along with consumables like cryogenic vials and culturing media, form the backbone of the system.
Cost Considerations: While initial costs can be high—ranging from $150 for small cryogenic tanks to over $1500 for larger freezers—the long-term benefits outweigh these expenses. Reduced labor costs, lower contamination risks, and prevention of strain senescence make cryopreservation a cost-effective choice.
Safety and Maintenance: Using liquid nitrogen (LN2) requires adherence to safety standards and proper personal protective equipment (PPE). The biggest risk is uncontrolled thawing due to tank failure, which underscores the importance of reliable LN2 supply and well-maintained storage equipment.
Operational Efficiency: The bulk of the work is front-loaded, with initial sample preparation and viability testing. Once established, maintaining the biobank requires minimal effort, with periodic checks and additions of new cultures.
![](https://static.wixstatic.com/media/1b52ec_eb26ffedc51443038ec88d353021390f~mv2.jpg/v1/fill/w_980,h_551,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/1b52ec_eb26ffedc51443038ec88d353021390f~mv2.jpg)
Cryogenic vial inoculation. Inoculation of a sterile cryogenic vial with cryogenic medium using a small (3 to 5 mm2) square of inoculum taken from a well-colonized MEA Petri dish.
Real-World Applications
The cryopreservation method has been tested across 61 genera and over 100 fungal species, proving effective even for those not commercially available. For example, the biobank includes 87 isolates of Laricifomes officinalis, a significant achievement given the species' potential pharmaceutical applications.
The Road Ahead
As human activities accelerate species extinction rates, preserving fungal diversity becomes increasingly critical. Despite being historically understudied, fungi are gaining recognition for their ecological and industrial importance. Cryopreservation can play a pivotal role in safeguarding this diversity, ensuring that future generations can continue to benefit from the myriad contributions of fungi.
In the burgeoning global mushroom market, valued at $29.1 billion in 2022 and projected to reach $65.8 billion by 2030, cryopreservation is not just a scientific endeavor but a commercial imperative. By making cryogenic biobanking more transparent and accessible, we can foster innovation and sustainability in both research and industry.
![](https://static.wixstatic.com/media/1b52ec_92da9049dea7490da6718ab17010943e~mv2.png/v1/fill/w_978,h_1304,al_c,q_90,enc_auto/1b52ec_92da9049dea7490da6718ab17010943e~mv2.png)
Cryopreservation offers a robust solution for the long-term preservation of fungal cultures. By leveraging simple, scalable methods, even modestly resourced laboratories can establish effective cryogenic biobanks. This approach not only conserves fungal biodiversity but also supports scientific discovery and commercial development, paving the way for a deeper understanding and utilization of these remarkable organisms.
Kommentarer